Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

British Journal of Cancer

Volumn 90, Issue 10, 2004, Pages 1983-1988

  Iniesta, P ^a   Gonzalez Quevedo R ^a   Moran A ^a   Garcia Aranda C ^a   De Juan, C ^a   Sanchez Pernaute A ^b   Torres, A ^b   Diaz Rubio E ^b   Balibrea, J L ^b   Benito, M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Chromosome 3p; Deletions; Non small cell lung cancer; Patient prognosis; Telomerase activity; Tumorigenesis

Indexed keywords

TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURGERY; CHROMOSOME 3P; CHROMOSOME DELETION; CHROMOSOME POLYMORPHISM; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REACTIVATION; FEMALE; GENE FUNCTION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR SUPPRESSOR GENE; CHROMOSOME 3; GENE DELETION; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; SURVIVAL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TELOMERASE;

EID: 2942624442     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601775     Document Type: Article

References (28)

1. Blin N, Stafford DW (1976) A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3: 2303-2308
2. Cong Y-S, Wright WE, Shay JW (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66(3): 407-425
3. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA (1998) Telomerase activity is restored in human cells by ectopic expression of hTERT catalytic subunit of telomerase. Oncogene 16: 1217-1222
4. Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriott A, Khoudoli G (1999) Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst 91: 37-45
5. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y (1999) Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 59: 1966-1972
6. Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T (2003) RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer 106: 45-51
7. Gazdar AF, Minna JD (1997) Cigarettes, sex, and lung adenocarcinoma. J Natl Cancer Inst 89: 1563-1565
8. González-Quevedo R, de Juan C, Massa MJ, Sánchez-Pernaute A, Torres A, Balibrea JL, Benito M, Iniesta P (2000) Detection of telomerase activity in human carcinomas using a TRAP-ELISA method: correlation with hTR and hTERT expression. Int J Oncol 16: 623-628
9. González-Quevedo R, Iniesta P, Morán A, de Juan C, Sánchez-Pernaute A, Fernández C, Torres A, Díaz-Rubio E, Balibrea JL, Benito M (2002) Cooperative role of telomerase activity and p16 expression in the prognosis of non-small cell lung cancer. J Clin Oncol 20(1): 254-262
10. Horikawa I, Oshimura M, Barrett JC (1998) Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinogen 22: 65-72
11. Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J (2003) Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res 63(13): 3743-3746
12. Kim NW, Piatyszek MA, Prowse KR Harley CB, West MD, Ho PI, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
13. Kok K, Naylor SL, Buys CH (1997) Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 71: 27-92
14. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM (2003) Allele loss and promoter hypermethylation of VHL, RAR-β, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63: 3724-3728
15. Mehle C, Lindblom A, Ljungberg B, Stenling R, Roos G (1998) Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int J Oncol 13(2): 289-295
16. Meyerson M (2000) Role of telomerase in normal and cancer cells. J Clin Oncol 18: 2626-2634
17. Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Sugio K, Yasumoto K, Sugimachi K, Gazdar AF (1996) Loss of heterozygosity at 3p in non-small-cell lung cancer and its prognostic implication. Clin Cancer Res 2: 1185-1189
18. Mountain CF (1986) A new international staging system for lung cancer. Chest 89(Suppl): 225-233
19. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M (1995) Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86: 899-904
20. Sato S, Nakamura Y, Tsuchiya E (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54: 5652-5655
21. Sobin L (1982) The World Health Organization's histological classification of lung tumors: a comparison of the first and second editions. Cancer Detect Prev 5: 391-406
22. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM (1996) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85(1): 17-26
23. Taga S, Osaki T, Ohgami A, Imoto H, Yasumoto K (1999) Prognostic impact of telomerase activity in non-small-cell lung cancers. Ann Surg 230: 715-720
24. Wei M-H, Latif F, Bader S, Kashuba V, Chen JY, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD (1996) Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res 56: 1487-1492
25. Wiest JS, Franklin WA, Drabkin H, Gemmill R, Sidransky D, Anderson MW (1997) Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention. J Cell Biochem 28/29(Suppl): 64-73
26. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon III JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S (2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60(7): 1949-1960
27. Xian J, Clark KJ, Fordham R, Pannell R, Rabbitts TH, Rabbitts PH (2001) Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene. Proc Natl Acad Sci USA 98(26): 15062-15066
28. Xinarianos G, Liloglou T, Prime W, Maloney P, Callaghan J, Fielding P, Gosney JR, Field JK (2000) hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res 60(15): 4216-4221